Preparation, writing and redaction of clinical study reports

BlueReg can support in preparing and writing clinical study reports

Providing the redaction proposal document package for submission to the European Medicines Agency (EMA); anonymising individual patient data (IPD) and redacting commercially confidential information (CCI) to comply with EMA policy 0070 on the publication of clinical data for medicinal products for human use.

 

 

Our experts

Associated News

EMA GUIDANCE – COVID-19

Given the support given to our clients in interactions with health authorities all around the...

Learn more

E-regulatory Summit starts in few days!

E-regulatory Summit starts in few days!    Marlene Schuppli Nollet and Franck VIGLIECCA will be pleased to invite...

Learn more

eCTD Format Mandatory for EU National Procedures

After CP, DCP/MRP Procedures, and according to the eSubmissions Roadmap Timelines, eCTD format is now...

Learn more

Register Now for our Next BlueReg Webinar !